Advances in unrelated and alternative donor hematopoietic cell transplantation for nonmalignant disorders

Shalini Shenoy, Jaap J. Boelens

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


PURPOSE OF REVIEW: The role of hematopoietic cell transplantation in non-malignant disorders has increased exponentially with the recognition that multiple diseases can be controlled or cured if engrafted with donor-derived cells. This review provides an overview of advances made in alternative donor transplants for nonmalignant disorders. RECENT FINDINGS: Stem cell sources, novel transplant methods, and sophisticated supportive care have simultaneously made giant strides toward improving the safety and efficacy of hematopoietic cell transplantation. This has led to the utilization of marrow, cord, peripheral blood stem cell and haploidentical stem cell sources, and novel reduced toxicity or reduced intensity conditioning regimens to transplant non-malignant disorders such as immune dysfunctions, marrow failure syndromes, metabolic disorders and hemoglobinopathies. Transplant complications such as graft rejection, infections, and graft versus host disease are better combated in this modern era of medicine, achieving better survival with decreased late effects. These aspects of transplant for non-malignant disorders are discussed. SUMMARY: This review presents the progress made in the realm of hematopoietic cell transplantation for non-malignant disorders. It advocates the consideration of alternative donor transplants in the absence of human leukocyte antigen matched siblings when indicated by disease severity. The ultimate goal is to provide curative transplant options for more patients that can benefit from this intervention, prior to detrimental outcomes.

Original languageEnglish
Pages (from-to)9-17
Number of pages9
JournalCurrent opinion in pediatrics
Issue number1
StatePublished - Feb 21 2015


  • alternative donors
  • hematopoietic stem cell transplant
  • nonmalignant disorders


Dive into the research topics of 'Advances in unrelated and alternative donor hematopoietic cell transplantation for nonmalignant disorders'. Together they form a unique fingerprint.

Cite this